Anti-nausea drug may be new treatment for obstructive sleep apnea
Can't see this email? View it online
   
  June 19, 2017  
  Pulmonology  
  The latest pulmonology news from News Medical  
 Anti-nausea drug may be new treatment for obstructive sleep apneaAnti-nausea drug may be new treatment for obstructive sleep apnea
 
An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual meeting in Boston.
 
 
 Study identifies new susceptibility loci for lung cancerStudy identifies new susceptibility loci for lung cancer
 
Using the OncoArray genotyping platform developed by multiple cancer consortia, a recent large aggregated genomewide association study identifies new susceptibility loci for lung cancer, the leading cause of cancer mortality worldwide.
 
   Peer-led self-management programs have little impact on quality of life of adolescents with asthmaPeer-led self-management programs have little impact on quality of life of adolescents with asthma
 
A study from the University of Warwick suggests peer-led self-management programs have little impact on the quality of life or lung function of adolescents with asthma.
 
   Melbourne study offers hope for better lung cancer treatmentMelbourne study offers hope for better lung cancer treatment
 
A Melbourne study is set to improve treatment options for patients with the second most common type of lung cancer, lung squamous cell carcinoma, a disease for which new anti-cancer drugs are urgently needed.
 
   Study: Men with sleep apnea and insomnia have higher prevalence, severity of depressionStudy: Men with sleep apnea and insomnia have higher prevalence, severity of depression
 
A new study found that men with sleep apnea and insomnia have a higher prevalence and severity of depressive symptoms than men with sleep apnea or insomnia alone.
 
 Customary drug dose for treatment of lung cancer may be higher than needed, study shows
 
Customary drug dose for treatment of lung cancer may be higher than needed, study showsA new study published in the Journal of the National Cancer Institute indicates that the customary pembrolizumab dose for treatment of metastatic non-small cell lung cancer may be higher than is needed for effective treatment.
 
 
 Scientists create method for mapping genome-wide DNA damage caused by chemical carcinogen
 
Scientists create method for mapping genome-wide DNA damage caused by chemical carcinogenScientists have known for decades that smoking cigarettes causes DNA damage, which leads to lung cancer. Now, for the first time, UNC School of Medicine scientists created a method for effectively mapping that DNA damage at high resolution across the genome.
 
 
 Findings point to potential new treatment for people with newly diagnosed EGFR-positive NSCLC
 
Findings point to potential new treatment for people with newly diagnosed EGFR-positive NSCLCFindings from a phase III clinical trial point to a potential new treatment for patients newly diagnosed with advanced, epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCLC).
 
 
 New biosensor technology could be used in wearable devices to monitor health
 
New biosensor technology could be used in wearable devices to monitor healthImagine wearing a device that continuously analyzes your sweat or blood for different types of biomarkers, such as proteins that show you may have breast cancer or lung cancer.
 
 
 JHH Nutrition Score can help quickly identify heart surgery patients at risk for malnutrition
 
JHH Nutrition Score can help quickly identify heart surgery patients at risk for malnutritionPatients who are at risk for malnutrition when undergoing heart surgery now can be more quickly and easily identified, leading to intervention and potentially better surgical outcomes, according to a study published online today in The Annals of Thoracic Surgery.
 
 
 When an insurer balks and treatment stops
 
When an insurer balks and treatment stopsGillen Washington, a student at Northern Arizona University, had been getting medication for an immunodeficiency disease since 2011. But when he went to his clinic in November 2014 for the monthly dose, a nurse told him his insurance company had denied it.
 
 
 New treatment strategy may destroy difficult-to-treat brain tumors
 
New treatment strategy may destroy difficult-to-treat brain tumorsA new strategy for treating brain tumors may extend or save the lives of patients diagnosed with one of the deadliest forms of cancer, according to a study from UT Southwestern Medical Center.
 
 
 FDA labeling rule helps providers better explain medication risks and benefits to pregnant, breastfeeding patients
 
FDA labeling rule helps providers better explain medication risks and benefits to pregnant, breastfeeding patientsThe new U.S. Food and Drug Administration's Pregnancy and Lactation Labeling Rule should help healthcare providers better explain to pregnant and breastfeeding patients the benefits and risks of taking a specific medication.
 
 
 New data reveals potential of snus in reducing impact of tobacco-related diseases
 
New data reveals potential of snus in reducing impact of tobacco-related diseasesNew data analysis presented today at the annual Global Forum on Nicotone meeting demonstrates the potential of the low-risk tobacco product snus in reducing the impact of tobacco-related disease and death in Europe.
 
 
 Tianjiu therapy enhances daily quality of life for allergic rhinitis patients, study finds
 
Tianjiu therapy enhances daily quality of life for allergic rhinitis patients, study findsThe School of Chinese Medicine of Hong Kong Baptist University (HKBU) recently conducted a "Tianjiu therapy for allergic rhinitis: A double-blinded randomised Placebo-controlled clinical trial".
 
 
 Cigarette smoking causes diverse harm that extends way beyond the lungs
 
Cigarette smoking causes diverse harm that extends way beyond the lungsWarning: Cigarette smoking presents far more health hazards than you probably realize.
 
 
 New data reveals increase in rate of deaths from Alzheimer's disease
 
New data reveals increase in rate of deaths from Alzheimer's diseaseThe rate of death from Alzheimer's disease in the United States increased by more than 50 percent in the past 15 years, according to new data from the Centers for Disease Control and Prevention.
 
 
 Antibody-based theranostic agent shows promise for identifying and treating pancreatic tumors
 
Antibody-based theranostic agent shows promise for identifying and treating pancreatic tumorsPancreatic cancer is associated with bleak five-year survival rates and limited treatment options, but new research is offering hope.
 
 
 Novel method using 3D-printed patches offers potential treatment for ischemia
 
Novel method using 3D-printed patches offers potential treatment for ischemiaIschemia results when narrowed, hardened or blocked blood vessels starve tissue, often resulting in heart attack, stroke, gangrene and other serious conditions.
 
 
 New genomic sequencing approach could be first step toward blood tests for early cancer detection
 
New genomic sequencing approach could be first step toward blood tests for early cancer detectionIn a study of 124 patients with advanced breast, lung, and prostate cancers, a new, high-intensity genomic sequencing approach detected circulating tumor DNA at a high rate.